Clinical Trial Update: Prochymal® (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI) [Phase 2]

View source ↗

Summary

Phase 2 trial of Prochymal (allogeneic human adult stem cells) given by IV after acute myocardial infarction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• PROCHYMAL (allogeneic mesenchymal stem cells)

Snippet

Sponsor: Mesoblast, Inc. | Conditions: Myocardial Infarction | Phase 2 | Status: COMPLETED